|
05 Apr 2025 |
HDFC Life Insurance
|
Consensus Share Price Target
|
689.05 |
775.67 |
- |
12.57 |
buy
|
|
|
|
|
28 Mar 2025
|
HDFC Life Insurance
|
Ventura
|
689.05
|
870.00
|
685.70
(0.49%)
|
26.26 |
Buy
|
|
|
A frontrunner in a growing industry
|
|
04 Mar 2025
|
HDFC Life Insurance
|
Sharekhan
|
689.05
|
870.00
|
616.50
(11.77%)
|
26.26 |
Buy
|
|
|
HDFC Life continues guide for 18-20% APE growth and >15% VNB growth in the next couple of quarters. APE growth remained healthy at 20% y-o-y while VNB grew by 14% y-o-y in 9MFY25.
|
|
30 Jan 2025
|
HDFC Life Insurance
|
Geojit BNP Paribas
|
689.05
|
722.00
|
634.15
(8.66%)
|
4.78 |
Buy
|
|
|
|
|
17 Jan 2025
|
HDFC Life Insurance
|
KRChoksey
|
689.05
|
820.00
|
642.20
(7.30%)
|
19.00 |
Buy
|
|
|
In Q3FY25, the Gross Written Premium (GWP) amounted to INR 172,750 Mn, marking an 11.6% YoY growth (-4.2% QoQ). While the growth was broad-based, the GWP lagged our estimates by 4.8%, driven by weaker-than-expected growth in both first-year premiums and renewals.
|
|
16 Jan 2025
|
HDFC Life Insurance
|
BOB Capital Markets Ltd.
|
689.05
|
755.00
|
641.40
(7.43%)
|
9.57 |
Buy
|
|
|
HDFCLIFE reported stronger-than-expected APE growth of 20%/12% YoY in 9MFY25/Q3FY25
|
|
16 Jan 2025
|
HDFC Life Insurance
|
Emkay
|
689.05
|
775.00
|
641.40
(7.43%)
|
12.47 |
Buy
|
|
|
HDFCLIFE reported an impressive performance in 9MFY25, with APE 1.6% above our estimate at Rs102.9bn, and VNB margin at 25.1% above our estimate of 24.5% resulting in a 4.2% beat on VNB at Rs25.9bn.
|
|
23 Oct 2024
|
HDFC Life Insurance
|
Geojit BNP Paribas
|
689.05
|
800.00
|
723.75
(-4.79%)
|
16.10 |
Buy
|
|
|
|
|
20 Oct 2024
|
HDFC Life Insurance
|
ICICI Direct
|
689.05
|
855.00
|
742.45
(-7.19%)
|
24.08 |
Buy
|
|
|
|
|
17 Oct 2024
|
HDFC Life Insurance
|
KRChoksey
|
689.05
|
845.00
|
726.10
(-5.10%)
|
22.63 |
Buy
|
|
|
In Q2FY25, the Gross Written Premium (GWP) amounted to INR 169,275 Mn (+13.3% YoY). The GWP fell short of our estimates due to lower-than-anticipated renewal premium growth.
|
|
16 Oct 2024
|
HDFC Life Insurance
|
Emkay
|
689.05
|
825.00
|
726.80
(-5.19%)
|
19.73 |
Buy
|
|
|
HDFCLIFE reported broadly in-line numbers for H1FY25, with APE 3.6% above our estimate at Rs67.2bn however, VNB Margin at 24.6% missed our estimate of 25.1% resulting in largely in-line VNB at Rs16.6bn.
|
|
15 Oct 2024
|
HDFC Life Insurance
|
Sharekhan
|
689.05
|
870.00
|
714.25
(-3.53%)
|
26.26 |
Buy
|
|
|
VNB margins lagged estimates, fell by ~200 bps y-o-y reported at 24.3% vs estimates of 25.4% due to adverse product mix and repricing of IRR downwards for some of the existing non-par savings & annuity products (one off item).
|
|
11 Sep 2024
|
HDFC Life Insurance
|
Sharekhan
|
689.05
|
870.00
|
700.15
(-1.59%)
|
26.26 |
Buy
|
|
|
We maintain a Buy on HDFC Life with a revised PT of Rs.870. The company is confident of growing retail APE higher than industry APE and doubling VNB every four years.
|
|
17 Jul 2024
|
HDFC Life Insurance
|
KRChoksey
|
689.05
|
765.00
|
646.75
(6.54%)
|
11.02 |
Buy
|
|
|
The Gross Written Premium (GWP) for Q1FY25 stood at INR 128,109 Mn, a growth of 9.7% YoY, primarily led by the renewal segment. On a QoQ basis, the GWP declined by 38.8% on account of a high base of Q4FY24.
|
|
17 Jul 2024
|
HDFC Life Insurance
|
ICICI Direct
|
689.05
|
750.00
|
646.75
(6.54%)
|
Target met |
Buy
|
|
|
|
|
16 Jul 2024
|
HDFC Life Insurance
|
ICICI Securities Limited
|
689.05
|
739.00
|
646.75
(6.54%)
|
Target met |
Buy
|
|
|
HDFC Life (HDFCLI) reported 18% growth in VNB YoY despite 113bps reduction in VNB margin to 25.1% in Q1FY25. This, along with strong 39% growth in non-par, 31% growth in individual protection and 22% growth in number of policies underline HDFCLI’s execution efforts as it aims to clock 18–20% VNB CAGR.
|
|
16 Jul 2024
|
HDFC Life Insurance
|
Motilal Oswal
|
689.05
|
750.00
|
646.75
(6.54%)
|
Target met |
Buy
|
|
|
HDFC Life Insurance (HDFCLIFE) in 1QFY25 reported lower-than-expected VNB margins at 25% (est. 26%), with absolute VNB increasing 18% YoY to INR7.2b (in line with estimate).
|
|
16 Jul 2024
|
HDFC Life Insurance
|
Emkay
|
689.05
|
750.00
|
646.75
(6.54%)
|
Target met |
Buy
|
|
|
HDFCLIFE reported broadly in-line results for Q1FY25, with APE at Rs28.6bn (+23% YoY), coming in 4% above our estimates and more than offsetting the slight margin miss at 25% (Emkay est.: 25.6%), leading to a ~2% beat in VNB at Rs7.18bn (Emkay: Rs7bn).
|
|
15 Jul 2024
|
HDFC Life Insurance
|
Sharekhan
|
689.05
|
750.00
|
638.05
(7.99%)
|
Target met |
Buy
|
|
|
HDFC Life reported broadly in-line performance, except VNB margins lagged estimates. APE grew by 23% y-o-y mainly driven by higher ULIP sales (up 99% y-o-y).
|
|
19 Jun 2024
|
HDFC Life Insurance
|
Geojit BNP Paribas
|
689.05
|
710.00
|
596.20
(15.57%)
|
Target met |
Buy
|
|
|
|
|
21 Apr 2024
|
HDFC Life Insurance
|
ICICI Securities Limited
|
689.05
|
739.00
|
601.55
(14.55%)
|
Target met |
Buy
|
|
|
HDFC Life (HDFCLI) has successfully worked its way to improve bancassurance as well as agency while focusing on SURU markets (semi-urban and rural) in FY24. This has led to 13% YoY growth in tier 2/3 locations while overall NoP has grown 11% YoY in FY24.
|